Treatment of insulin lipoatrophy with monocomponent insulin.
D000273:Adipose Tissue / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D000818:Animals; D001706:Biopsy; D002417:Cattle; D003920:Diabetes Mellitus / Q000188:drug therapy; D004340:Drug Contamination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use; D007330:Insulin Antibodies / Q000032:analysis; D049528:Insulin, Long-Acting / Q000627:therapeutic use*; D008060:Lipodystrophy / Q000139:chemically induced / Q000188:drug therapy*; D008875:Middle Aged; D011384:Proinsulin / Q000627:therapeutic use; D013552:Swine
D007328:Insulin; D007330:Insulin Antibodies; D049528:Insulin, Long-Acting; D011384:Proinsulin